NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma.
about
Asthma control: the right inhaler for the right patientMultivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder InhalerAccessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation.Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma.Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on AsManifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on AsThe role of the small airways in the pathophysiology of asthma and chronic obstructive pulmonary disease.Maintaining Control of Chronic Obstructive Airway Disease: Adherence to Inhaled Therapy and Risks and Benefits of Switching Devices.Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.Dry powder inhalation: past, present and future.Inhalation devices: from basic science to practical use, innovative vs generic products.The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways.Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma.Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler Device in Healthy Subjects, Asthmatic Patients, and COPD PatientsIs there room for further innovation in inhaled therapy for airways disease?
P2860
Q26863778-A9B65090-DB18-47E4-B143-9D7B6F1F2A98Q30390980-A0939BA9-E8FD-4E89-8E35-96D05267B87BQ33468788-BE7288AB-B13B-4761-8A80-05922192D11DQ36970994-93E86C21-C4C9-4E9B-93E2-507831DC4C74Q37374602-64424A5E-BD2D-4C96-A581-EA54709EB243Q37481285-B34F27C5-DB9F-4E9E-A0D0-CDE11A3042E5Q38513898-DB80F04E-BA42-48F4-B3D3-B37351EAA7C3Q38593048-2C1A801A-07ED-455D-9721-48E5D91E43ACQ38759118-7F394023-4D40-4B79-8BDD-547D43333A48Q38830375-DC19C22C-FD1F-44DA-84D6-A9032301602BQ38856654-0F2B67BE-724B-48B9-9EB3-8C4EE971B44BQ38980035-899DB0F0-597A-4CE2-BFD7-CA133DCF0EFDQ40526870-AE86CCD0-5BEA-49CC-B4F1-01452E460498Q47652466-709E716E-B308-4EB3-A97A-7B45813EA5ECQ55041230-1FFB2328-9EFA-418A-8B5A-EE8DE64907BCQ55317003-5C78921B-E7AE-46F4-A63C-6701EC68ACD3Q58694730-7244B1B9-D2CF-4CCE-AE51-B2A9007B6E34Q58777102-3A6A97EE-3FB3-48EF-BBF8-5A4114A28926
P2860
NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
NEXThaler, an innovative dry p ...... e and small airways in asthma.
@en
type
label
NEXThaler, an innovative dry p ...... e and small airways in asthma.
@en
prefLabel
NEXThaler, an innovative dry p ...... e and small airways in asthma.
@en
P2093
P2860
P1476
NEXThaler, an innovative dry p ...... e and small airways in asthma.
@en
P2093
Henry Chrystyn
Michal Pirozynski
Monica Spinola
Omar S Usmani
Renaud Louis
Stelios Loukides
P2860
P304
P356
10.1517/17425247.2014.928282
P407
P577
2014-06-12T00:00:00Z